Integral Diagnostics (Integral Diagnostics) EV-to-EBIT : -28.00 (As of May. 12, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Integral Diagnostics EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Integral Diagnostics's Enterprise Value is $606.0 Mil. Integral Diagnostics's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-21.6 Mil. Therefore, Integral Diagnostics's EV-to-EBIT for today is -28.00.

The historical rank and industry rank for Integral Diagnostics's EV-to-EBIT or its related term are showing as below:

ITGDF' s EV-to-EBIT Range Over the Past 10 Years
Min: -33.17 Med: 18.58 Max: 28.62
Current: -28.56

During the past 8 years, the highest EV-to-EBIT of Integral Diagnostics was 28.62. The lowest was -33.17. And the median was 18.58.

ITGDF's EV-to-EBIT is ranked worse than
100% of 106 companies
in the Medical Diagnostics & Research industry
Industry Median: 21.34 vs ITGDF: -28.56

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Integral Diagnostics's Enterprise Value for the quarter that ended in Dec. 2023 was $696.8 Mil. Integral Diagnostics's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-21.6 Mil. Integral Diagnostics's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -3.11%.

Integral Diagnostics EV-to-EBIT Historical Data

The historical data trend for Integral Diagnostics's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Integral Diagnostics EV-to-EBIT Chart

Integral Diagnostics Annual Data

Trend

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

EV-to-EBIT

Get a 7-Day Free Trial

16.69

22.35

23.63

27.60

22.36

Integral Diagnostics Semi-Annual Data
	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EV-to-EBIT	Get a 7-Day Free Trial												-	27.60	-	22.36	-

Competitive Comparison of Integral Diagnostics's EV-to-EBIT

For the Diagnostics & Research subindustry, Integral Diagnostics's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Integral Diagnostics's EV-to-EBIT Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Integral Diagnostics's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Integral Diagnostics's EV-to-EBIT falls into.

Integral Diagnostics EV-to-EBIT Calculation

Integral Diagnostics's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	605.952	/	-21.645
	=	-28.00

Integral Diagnostics's current Enterprise Value is $606.0 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Integral Diagnostics's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-21.6 Mil.

Integral Diagnostics (OTCPK:ITGDF) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Integral Diagnostics's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 )	=	EBIT	/	Enterprise Value (Q: Dec. 2023 )
	=	-21.645	/	696.771
	=	-3.11 %

Integral Diagnostics's Enterprise Value for the quarter that ended in Dec. 2023 was $696.8 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Integral Diagnostics's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-21.6 Mil.

Integral Diagnostics EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Integral Diagnostics's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Integral Diagnostics (Integral Diagnostics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Integral Diagnostics Ltd (OTCPK:ITGDF) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

IDX:Australia

Address

45 William Street, Suite 9.02, Level 9, Melbourne, VIC, AUS, 3000

Website

http://www.integraldiagnostics.com.au

Integral Diagnostics is Australia's fourth-largest diagnostic imaging provider. In Australia, imaging revenues are almost entirely earned via the public health Medicare system. Integral typically earns approximately 90% of group revenue from diagnostic imaging in Australia and the remainder from diagnostic imaging in Auckland, New Zealand. In Australia, Integral services regional areas in Queensland, Victoria, New South Wales, and Western Australia.